11th Circuit Dupixent news shows skin cancer cases across Alabama, Florida, and Georgia. While the full extent of lymphoma unmasking continues to emerge, MDL compensation is now being sought for eczema and asthma medication victims.
To learn more, please see our information on claiming an 11th Circuit Dupixent settlement.
Alabama Dupixent News
Alabama Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.
- AL Dupixent News – Coming Soon / As Available
If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing an Alabama Dupixent lawsuit.
Florida Dupixent News
Florida Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.
- FL Dupixent News – Coming Soon / As Available
If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing a Florida Dupixent lawsuit.
Georgia Dupixent News
Georgia Dupixent news reports indicate widespread development or unmasking of T-Cell lymphoma.
- GA Dupixent News – Coming Soon / As Available
If you were diagnosed with skin cancer following eczema or asthma treatment, contact us about filing a Georgia Dupixent lawsuit.
11th Circuit Dupixent News Supports MDL Settlement for Skin Cancer
11th Circuit Dupixent news of T-cell lymphoma has raised concerns for eczema and asthma patients in Alabama, Florida, and Georgia. As such, public support is growing for the court’s certification of a Dupixent Multi-District Litigation (MDL) to administer claims.
Lymphoma Attorneys Act on 11th Circuit Dupixent News of Skin Cancer
Reporting skin cancer is an important first step to justice. If your family has been impacted by Dupixent, contact us about filing an 11th Circuit settlement claim.
For background information on T-cell lymphoma, please see our Dupixent lawyers homepage.